MedPath

A clinical research to study the effect of Sirunerunjil kudineer on KALLADAIPPU(urinary stones)

Phase 2
Recruiting
Conditions
KALLADAIPPU
Registration Number
CTRI/2017/08/009576
Lead Sponsor
S Neelavathi
Brief Summary

The study is prospective open Labeled randomized phase II clinical trial to evaluate the therapeutic efficacy of trial drug Siru nerunjil kudineer 40ml Bd for 30 days on the 40 patients with KALLADAIPPU that will be conducted in Government Siddha Medical college and hospital Palayamkottai The primary outcome will be the therapeutic efficacy of trial drug Sirunerunjil kudineer The secondary outcome will be the evaluation of Siddha diagnostic parameters

Detailed Description

Not available

Recruitment & Eligibility

Status
Open to Recruitment
Sex
All
Target Recruitment
40
Inclusion Criteria

Patient with appropriate symptoms of renal colic pain nausea or vomiting haematuria oliguria dysuria excessive sweating Patient who are willing to sign consent form and undergo laboratory investigations.

Exclusion Criteria

Pregnant and lactating women Diabetes mellitus Chronic appendicitis Pyelonephritis Cholecystitis Systemic hypertension Recurrent UTI Chronic kidney disease Bilateral obstructive uropathy.

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Therapeutic efficacy of Siru nerunjil kudineer on KALLADAIPPU30 days
Secondary Outcome Measures
NameTimeMethod
Evaluation of Siddha diagnostic parameters30 days

Trial Locations

Locations (1)

Government Siddha Medical college and hospital

🇮🇳

Tirunelveli, TAMIL NADU, India

Government Siddha Medical college and hospital
🇮🇳Tirunelveli, TAMIL NADU, India
T Seethalakshmi
Principal investigator
9688588793
baboo1726@gmail.com

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.